AAPP opposes the SAMHSA policy change to prohibit the use of federal funds for the purchase of “fentanyl test strips or any other substance test kits intended for use by people using drugs.” Test strips are an essential component of overdose prevention interventions. Access AAPP’s Policy Statement “The funding and delivery of harm reduction services” to support your advocacy.